Adenosine receptor antagonism in acute tacrolimus toxicity

Nephrology Dialysis Transplantation

Volumn 21, Issue 7, 2006, Pages 1961-1965

  McLaughlin, Gwenn E ^a   Alva, Maria D ^a   Egea, Marcelo ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; Adenosine antagonist; Calcineurin inhibitor; Glomerular filtration rate; Prograf; Purinergic; Receptors; Tacrolimus

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 8 (3 CHLOROSTYRYL)CAFFEINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; CHROMIUM 51; DIMETHYL SULFOXIDE; DRUG VEHICLE; EDETIC ACID; RECEPTOR SUBTYPE; TACROLIMUS; THEOPHYLLINE;

ANALYSIS OF VARIANCE; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG TOXICITY; GLOMERULUS FILTRATION RATE; INSTRUMENTATION; KIDNEY CLEARANCE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR BLOCKING; STATISTICAL SIGNIFICANCE;

ANIMALS; GLOMERULAR FILTRATION RATE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; PURINERGIC P1 RECEPTOR ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; RENAL CIRCULATION; TACROLIMUS; THEOPHYLLINE;

EID: 33745595854     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl082     Document Type: Article

References (34)

1. Scott LJ, McKeage K, Keam SJ, Plosker GL. Tacrolimus: A further update of its use in the management of organ transplantation. Drugs 2003; 63: 1247-1297
2. Guieu R, Dussol B, Devaux C et al. Interactions between cyclosporine A and adenosine in kidney transplant recipients. Kidney Int 1998; 53: 200-204
3. Hwang K, Hall CS, Spielman WS, Sparks HV. FK506 promotes adenosine release from endothelial cells via inhibition of adenosine kinase. Eur J Pharmacol 2001; 425: 85-93
4. Spychala J, Mitchell BS. Cyclosporin and FK506 decrease adenosine kinase activity and adenosine uptake in T-lymphocytes. J Lab Clin Med 2002; 140: 84-91
5. Osswald H, Gleiter C, Muhlbauer BP. Therapeutic use of theophylline to antagonize renal effects of adenosine. Clin Nephrol 1995; 43: S33-S37
6. Yaar R, Jones MR, Chen JF, Ravid K. Animal models for the study of adenosine receptor function. J Cell Physiol 2005: 202; 9-20
7. 1 receptor antagonist in the kidney. Curr Opin Nephrol Hypertens 2003; 12: 487-502
8. 3 receptors: Novel ligands and paradoxical effects. TiPS 1998; 19: 184-191
9. McLaughlin GE, Kashimawo L, Steele B, Kuluz JW. Reversal of acute tacrolimus-induced renal vasoconstriction by theophylline in rats. Pediatr Crit Care Med 2003; 4: 358-362
10. McLaughlin GE, Abitbol CL. Reversal of oliguric tacrolimus nephrotoxicity in children. Nephrol Dial Transplant 2005; 20: 1471-1475
11. Lee TH, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: Role of A1 and A3 receptors. Am J Physiol Renal Physiol. 2000; 278: F380-F387
12. Hiraide T, Katsura K, Muramatsu H, Asano G, Katayama Y. Adenosine receptor antagonists cancelled the ischemic tolerance phenomenon in gerbil. Brain Res 2001; 910: 94-98
13. 2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Res 1995; 705: 79-84
14. 2 adenosine antagonist in vivo and in vitro. FEBS Letters 1993; 323: 141-144
15. Tomic MA, Vuckovic SM, Stepanovic-Petrovic RM, Ugresic N, Prostram MS, Boskovic B. The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists. Pain 2004; 111: 253-260
16. 2a receptor agonist and antagonist. Eur J Pharmacol 1995; 287: 295-302
17. 3 adenosine receptors attenuates lung injury after in vivo reperfusion. Anesthesiology 2004; 101: 1153-1159
18. 51Cr] EDTA for measuring total and single nephron glomerular filtration rate in rat. Acta Physiol Scand 1995; 153: 271-277
19. Prevot A, Mosig D, Rijtema M, Guignard J-P. Renal effects of adenosine Al-receptor blockade with 8-cyclopentyl-1,3-dipropylxanthine in hypoxemic newborn rabbits. Pediatr Res 2003; 54: 400-405
20. Heyne N, Wolf S, Petersen et al. Adenosine receptor antagonism in the prevention of acute cyclosporine A nephrotoxicity in normal, diabetic antihypertensive rats. Nephrol Dial Transplant 1999; 14 [Suppl 4]: 232-234
21. Kost CK, Herzer WA, Rominski BR, MI Z, Jackson EK. Diuretic response to adenosine A1 receptor blockade in normal tests about spontaneously hypertensive rats: Role of pertussis toxin-sensitive G-proteins. J Pharmacol Exp Ther 2002; 292: 752-760
22. 1 receptors for the diuretic and natriuretic action of the methylxanthines theophylline and caffeine. J Pharmacol Exp Ther 2005; 313: 403-409
23. Bak M, Thomsen K. Effects of the adenosine A1 receptor inhibitor K838 on proximal tubular fluid output in rats. Nephrol Dial Transplant 2004: 19; 1077-1082
24. Okusa MD. A2a adenosine receptor: A novel therapeutic target in renal disease. Am J Physiol Renal Physiol 2002: 282; F10-F18
25. Lee HT, Emala CW. Systemic adenosine given after ischemia protects renal function via A(2a) adenosine receptor activation. Am J Kidney Dis 2001; 38: 610-618
26. Jackson EK, Zhu C, Tofovic SP. Expression of adenosine receptors in the preglomerular microcirculation. Am J Physiol Renal Physiol 2002; 283: F41-F51
27. Reshkin SJ, Guerra L, Bagorda A et al. Activation of A3 adenosine receptor induces calcium entry and chloride secretion in A6 cells. J Membrane Biol 2000: 178; 103-113
28. Lee HT, Ota-Setlik A, Xu H, D'Agati VD, Jacobson MA, Emala CW. A3 adenosine receptor knockout mice are protected against ischemia and myoglobinuria-induced renal failure. Am J Physiol Renal Physiol 2003; 284: F267-F273
29. Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. New Engl J Med 2003; 349: 931-940
30. Prevot A, Liet JM, Semama DS, Justrabo E, Guignard JP, Gouyon JB. Disparate effects of chronic and acute theophylline on cyclosporine A nephrotoxicity. Pediatr Nephrol 2002; 17: 418-424
31. McLaughlin GE, Schober M, Perez M, Ruiz P, Steele BW, Abitbol C. Benefit of theophylline administration in tacrolimus-induced nephrotoxicity in rats. Pediatr Nephrol 2003; 18: 860-864
32. Gerkens JF, Smith AJ. Effect of captopril and theophylline treatment in cyclosproine induced nephrotoxicity in rats. Transplantation 1985; 40: 213-214
33. Andoh TF, Burdmann EA, Lindsley J, Houghton DC, Bennett WM. Functional and structural characteristics of experimental FK 506 nephrotoxicity. Clin Experimental Pharmacol Physiol 1995; 22: 646-654
34. Lee HT, Xu H, Nasr SH, Schnermann J, Emala CW. A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. Am J Physiol Renal Physiol 2004; 286: F298-F306